- Home
- WDH vs DAWN Comparison
WDH vs DAWN Comparison
Compare WDH & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- DAWN
- Stock Information
- Founded
- WDH 2016
- DAWN 2018
- Country
- WDH China
- DAWN United States
- Employees
- WDH N/A
- DAWN N/A
- Industry
- WDH Specialty Insurers
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- WDH Finance
- DAWN Health Care
- Exchange
- WDH Nasdaq
- DAWN Nasdaq
- Market Cap
- WDH 651.0M
- DAWN 624.8M
- IPO Year
- WDH 2021
- DAWN 2021
- Fundamental
- Price
- WDH $1.84
- DAWN $7.20
- Analyst Decision
- WDH
- DAWN Strong Buy
- Analyst Count
- WDH 0
- DAWN 7
- Target Price
- WDH N/A
- DAWN $27.86
- AVG Volume (30 Days)
- WDH 278.4K
- DAWN 2.1M
- Earning Date
- WDH 09-04-2025
- DAWN 08-05-2025
- Dividend Yield
- WDH 2.21%
- DAWN N/A
- EPS Growth
- WDH 118.23
- DAWN N/A
- EPS
- WDH 0.15
- DAWN N/A
- Revenue
- WDH $388,729,415.00
- DAWN $187,638,000.00
- Revenue This Year
- WDH N/A
- DAWN $16.42
- Revenue Next Year
- WDH $9.29
- DAWN $47.52
- P/E Ratio
- WDH $11.81
- DAWN N/A
- Revenue Growth
- WDH 3.35
- DAWN 2190.50
- 52 Week Low
- WDH $0.97
- DAWN $5.64
- 52 Week High
- WDH $2.17
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- WDH 58.63
- DAWN 62.39
- Support Level
- WDH $1.76
- DAWN $6.71
- Resistance Level
- WDH $1.86
- DAWN $7.12
- Average True Range (ATR)
- WDH 0.07
- DAWN 0.32
- MACD
- WDH -0.01
- DAWN 0.10
- Stochastic Oscillator
- WDH 65.83
- DAWN 85.05
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.